Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02166359Completed
Randomised trial of icodextrin in end stage renal disease (ESRD) (2 arms), sponsored by Dong-A University. Primary endpoint: Mean difference and change of triglyceride levels at 3 months. Started Jun 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02166359.